SA
JAZZ icon

Sanctuary Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sanctuary Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Sell
1,945
-76
-4% -$16.6K ﹤0.01% 2022
2026
Q1 		$382K Buy
2,021
+204
+11% +$35.7K ﹤0.01% 1943
2025
Q4 		$309K Sell
1,817
-36
-2% -$5.52K ﹤0.01% 1992
2025
Q3 		$244K Sell
1,853
-487
-21% -$58.4K ﹤0.01% 2132
2025
Q2 		$248K Sell
2,340
-11,735
-83% -$1.27M ﹤0.01% 2028
2025
Q1 		$1.75M Buy
14,075
+882
+7% +$115K 0.01% 836
2024
Q4 		$1.65M Buy
13,193
+1,439
+12% +$170K 0.01% 973
2024
Q3 		$1.49M Buy
11,754
+9,804
+503% +$1.07M 0.01% 1046
2024
Q2 		$213K Buy
+1,950
New +$214K ﹤0.01% 2148

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sanctuary Advisors's JAZZ Position: Q2 2026 in Review

Sanctuary Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.8% in Q2 2026, selling an estimated $16.6K and leaving 1,945 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Sanctuary Advisors first reported a position in JAZZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.75M in Q1 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Sanctuary Advisors held 1,945 shares of Jazz Pharmaceuticals worth $469K as of Q2 2026.
  • Sanctuary Advisors sold 76 Jazz Pharmaceuticals shares in Q2 2026, an estimated $16.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2022 holding.
  • Sanctuary Advisors first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Jazz Pharmaceuticals position peaked at $1.75M in Q1 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.